J. Mitchell Jones, J.D., Ph.D.
Founding Shareholder
Dr. Jones is an expert in patent acquisition, litigation, and licensing, with a focus on life sciences, including areas like nutraceuticals, biotechnology, and nanotechnology.

Dr. Jones counsels clients on patent, trademark and trade secret issues. Dr. Jones has extensive experience in obtaining, litigating and licensing patents. Dr. Jones has a special emphasis in patents in life science disciplines, and has obtained hundreds of patents worldwide for clients in the following areas: fatty acid nutraceuticals, retroviral vectors, cell culture, recombinant proteins, transgenic animals, stem cells, transgenic plants, plant cultivars, plant transformation, bioenergy and biofuels, cold storage of organs, liquid crystals, nanotechnology, high-throughput screening methodologies, artificial skin, cell assays, and biochips.
Dr. Jones has experience in representing US and international companies, from start-ups to Fortune 500 companies, as well as leading United States universities. Dr. Jones actively participates with clients in designing sophisticated intellectual property protection strategies for their assets and for the maximization of their intellectual property resources (IPR), as well as strategies for assuring freedom to operate in complex business environments.
- Attorney, Casimir Jones, S.C., 2007 to present,
- Attorney, Medlen & Carroll, LLP, 1999-2007
- Attorney, Michael Best and Friedrich, 1997-1999
- J.D., Vanderbilt University 1997
- Ph.D., Endocrinology and Reproductive Physiology, University of Wisconsin 1994
- B.S., Animal Science, University of Tennessee-Martin 1988
- United States Patent and Trademark Office
- United States District Court, Western District of Wisconsin
- United States Court of Appeals for the Federal Circuit
- State Bar of Wisconsin
Hoffmann-LaRoche, Inc. v. Promega Corporation
1999 U.S. Dist. LEXIS 19059 (N.D. Cal 1999)
323 F.3d 1354, 66 USPQ2d 1385 (Fed. Cir. 2003)
2003 US. App. LEXIS 14802 (Fed. Cir. 2003)
Wisconsin Alumni Research Foundation v. Xenon Pharmaceuticals Inc., (W.D. Wis.)
- “Cell Cycle Mediated Repression of Transcription in Mammalian Embryos,” Ph.D. Thesis, University of Wisconsin (1994).
- “Expression of the Cell Cycle Control Protein cdc25 in Cleavage Stage Bovine Embryos,” Zygote 3(2):133-139 (1995).